Education
About Us
Working with TipRanks
Follow Us
Medpace Holdings (MEDP)
NASDAQ:MEDP
MEDP Analyst Ratings
Moderate Buy
2 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MEDP Stock 12 Month Forecast
Average Price Target
$346.67
▲(13.78% Upside)
| Highest Price Target$370.00 | Average Price Target$346.67 | Lowest Price Target$330.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Robert W. Baird
Reiterated
03/31/25
Leerink Partners
Initiated
03/24/25
TD Cowen
Reiterated
03/03/25
Truist Financial
Reiterated
02/11/25
Mizuho Securities
Reiterated
02/10/25
Jefferies
$305
Hold
0.10%
Upside
Assigned
10/22/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medpace Holdings (NASDAQ: MEDP), Biohaven Ltd. (NYSE: BHVN) and Intra-Cellular Therapies (NASDAQ: ITCI)
Unknown Analyst
Not Ranked
Redburn Atlantic
$404
Buy
32.59%
Upside
Initiated
10/14/24
Redburn-Atlantic starts Medpace (MEDP) at BuyRedburn-Atlantic initiates coverage on Medpace (NASDAQ: MEDP) with a Buy rating and a price target of $404.00.
UBS
$480→$350
Hold
14.87%
Upside
Downgraded
09/26/24
Maintaining Hold on Medpace Holdings Amid Market Headwinds and Revised Growth Expectations
Guggenheim
$464→$432
Buy
41.78%
Upside
Reiterated
07/24/24
Medpace price target lowered to $432 from $464 at GuggenheimMedpace price target lowered to $432 from $464 at Guggenheim
Deutsche Bank
$336
Hold
10.28%
Upside
Assigned
07/24/24
Medpace Holdings: Caution Ahead Despite Strong Performance - Hold Rating Justified
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Robert W. Baird
Reiterated
03/31/25
Leerink Partners
Initiated
03/24/25
TD Cowen
Reiterated
03/03/25
Truist Financial
Reiterated
02/11/25
Mizuho Securities
Reiterated
02/10/25
Jefferies
$305
Hold
0.10%
Upside
Assigned
10/22/24
Analysts Have Conflicting Sentiments on These Healthcare Companies: Medpace Holdings (NASDAQ: MEDP), Biohaven Ltd. (NYSE: BHVN) and Intra-Cellular Therapies (NASDAQ: ITCI)
Unknown Analyst
Not Ranked
Redburn Atlantic
$404
Buy
32.59%
Upside
Initiated
10/14/24
Redburn-Atlantic starts Medpace (MEDP) at BuyRedburn-Atlantic initiates coverage on Medpace (NASDAQ: MEDP) with a Buy rating and a price target of $404.00.
UBS
$480→$350
Hold
14.87%
Upside
Downgraded
09/26/24
Maintaining Hold on Medpace Holdings Amid Market Headwinds and Revised Growth Expectations
Guggenheim
$464→$432
Buy
41.78%
Upside
Reiterated
07/24/24
Medpace price target lowered to $432 from $464 at GuggenheimMedpace price target lowered to $432 from $464 at Guggenheim
Deutsche Bank
$336
Hold
10.28%
Upside
Assigned
07/24/24
Medpace Holdings: Caution Ahead Despite Strong Performance - Hold Rating Justified
MEDP Analyst Recommendation Trends
Rating
Nov 24
Dec 24
Jan 25
Feb 25
Mar 25
Strong Buy
0
0
0
0
0
Buy
4
3
1
3
4
Hold
7
6
3
5
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
9
4
8
10
Each month's total comprises the sum of three months' worth of ratings.
MEDP Financial Forecast
MEDP Stock Forecast FAQ
What is MEDP’s average 12-month price target, according to analysts?
Based on analyst ratings, Medpace Holdings’s 12-month average price target is $346.67.
What is MEDP’s upside potential, based on the analysts’ average price target?
Medpace Holdings has 13.78% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MEDP a Buy, Sell or Hold?
Medpace Holdings has a consensus rating of Moderate Buy which is based on 2 buy ratings, 3 hold ratings and 0 sell ratings.
What is Medpace Holdings’s price target?
The average price target for Medpace Holdings is $346.67. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $370.00 ,the lowest forecast is $330.00. The average price target represents 13.78% Increase from the current price of $304.69.
The highest analyst price target is $370.00 ,the lowest forecast is $330.00. The average price target represents 13.78% Increase from the current price of $304.69.
What do analysts say about Medpace Holdings?
Medpace Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
How can I buy shares of MEDP?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.